E-mail: zuze@vfn.cz
Sekce ČOS: Neuroonkologická sekce
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- Acquisition of Isochromosome 7 Is a Late Change in the Pathogenesis of Hepatosplenic Lymphoma, Documented On a Case of Adolescent Girl 5 Years After Renal Transplant with Preceding TCR Gamma-Delta Positive LGL Leukemia
- Acute Leukaemias with TEL/ABL Fusion: a Subgroup with Poor Prognosis and Prenatal Origin
- Amplifikácia MLL génu u pacienta s akútnou myeloidnou leukémiou (AML)
- ANALYSIS OF RISK FACTORS OF 248 PATIENTS WITH B-CHRONIC LYMPHOCYTIC LEUKEMIA AT DIAGNOSIS
- ATYPICAL DELETED SEGMENTS IN THREE PATIENTS WITH MYELOID MALIGNANCIES AND DELETION 5Q
- B Precursor ALL Subset with Aberrant CD2 Expression and a Specific Predisposition to Early Monocytic Transdifferentiation
- Backtracking Of The Genetic Events Preceding Acute Leukemia Diagnosis
- BCR-ABL MUTATED CLONE PROGRESSION AND ELIMINATION IN CML PATIENTS TREATED WITH ABL KINASE INHIBITORS
- Biology of Childhood Acute Hybrid Leukemias in a Population-Based Study (Czech Pediatric Hematology Working Group).
- Can Gene Methylation, Telomere Length and Activity of Telomerase Help with Individual Risk and Treatment Strategy of MDS Patients?
- Clinical Relevance of Complex Chromosomal Aberrations in Bone Marrow Cells of 107 Children with ETV6/RUNX1 Positive Acute Lymphoblastic Leukemia (ALL).
- CLONAL EVOLUTION STUDIED BY I-FISH IN B-CLL
- Clonal Heterogeneity in Patients with Myelodysplastic Syndromes (MDS) and Complex Karyotypes
- COMPLEX CHROMOSOMAL ABERRATIONS IN BONE MARROW CELLS OF 86 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
- COMPLEX CHROMOSOMAL REARRANGEMENTS IN ADULT PATIENTS WITH AML ARE INDEPENDENT PROGNOSTIC FACTOR
- COMPOSITION OF BONE MARROW SUBPOPULATIONS ANALYZED BY FLOW CYTOMETRY REVEALS DIFFERENCES BETWEEN PEDIATRIC APLASTIC ANEMIA AND REFRACTORY CYTOPENIA
- Composition of Cellular Subsets by Flow Cytometry Identifies Differences Between MDS Subtypes and Aplastic Anemia but No Differences Are Identified Between Cases with and without Monosomy 7
- CORRELATIONS AMONG CFU-GM GROWTH PATTERNS AND ACUTE LEUKEMIA WHO-2008 ENTITIES
- Defect in B Cell Production Driven By GATA2 Mutation Results in Their Absolute Reduction and Mature Phenotype in Pediatric Patients
- DETECTION OF STRUCTURAL ABERRATIONS OF CHROMOSOME 7 IN MYELOID MALIGNANCIES USING COMBINATION OF MOLECULAR CYTOGENETIC TECHNIQUES
- Differences in Cyto- and Molecular Genetic Abnormalities between Children
- DIFFERENT CONTROL GENES IN BCR/ABL MONITORING BY REAL-TIME RT-PCR
- Distribution and Outcome According to Cytogenetics in 502 Paediatric AML Patients Treated in Study AML-BFM 98
- Druhá celostátní léčebná studie AML-BFM 98 zvýšila úspěšnost v dosažení remise i celkové přežití dětí s akutní myeloidní leukémií v České republice
- Dynamics and Evolution of the Preleukemic Clone in Slow Onset Leukemias
- DYNAMICS OF TELOMERE LENGTH, THE STATUS OF CDKN2B GENE METHYLATION AND TELOMERASE ACTIVITY AS A POTENTIAL UNSPECIFIC PROGNOSTIC MARKERS IN MDS
- Epigenetic Changes in CEBPα Gene and Xenotransplantation Model of B Cell Precursor Acute Lymphoblastic Leukemia Switching to Monocytoid Lineage During the Early Phase of the Treatment
- FREQUENCY AND CLINICAL IMPLICATIONS OF ADDITIONAL CHROMOSOMAL ABERRATIONS IN ETV6/RUNX1 POSITIVE CHILDHOOD ALL
- Frequency and Prognostic Impact of Complex Chromosomal Aberrations in Patients with Primary Myelodysplastic Syndromes and Del(5q)
- GAIN/AMPLIFICATION OF 1Q21 IS THE MOST POWERFUL GENETIC PROGNOSTIC FACTOR FOR PATIENTS TREATED BY AUTOLOGOUS STEM CELL TRANSPLANTATION
- Changes Identified by Flow Cytometry and WT1 Expression in Consecutive Bone Marrow Samples in Refractory Cytopenia of Childhood and Aplastic Anemia Before Start of the Therapy
- CHROMOSOME 3 ABERRATIONS IN MYELOID MALIGNANCIES REVEALED BY MOLECULAR CYTOGENETIC TECHNIQUES AND THEIR PROGNOSTIC SIGNIFICANCE
- CHROMOTHRIPSIS IN BONE MARROW CELLS OF ADULT PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) WITH COMPLEX KARYOTYPES
- I-FISH ANALYSIS OF IMMUNOFLUORESCENTLY LABELED PLASMA CELLS IN PATIENTS WITH MULTIPLE MYELOMA
- IMATINIB IN THE TREATMENT OF ELDERLY PATIENTS WITH PH CML IN THE LATE CHRONIC PHASE
- Incidence a prognostický význam chromozomových změn u myelodysplastického syndromu
- Kdy a jak analyzovat mutace v kinázové doméně BCR-ABL u pacientů s CML?
- Komplexní změny karyotypu u pacientů s mnohočetným myelomem (MM)
- MLL Translocation in a Multipotent Progenitor Causing Acute Lymphoblastic Leukaemia Two-Step Model of the Disease
- MLL TRANSLOCATION IN A MULTIPOTENT PROGENITOR CAUSING ACUTE LYMPHOBLASTIC LEUKAEMIA - TWO-STEP MODEL OF THE DISEASE
- Modeling Resistance To Tyrosine Kinase Inhibitors In TEL/ABL-Positive Acute Lymphoblastic Leukemia
- MODELING RESISTANCE TO TYROSINE KINASE INHIBITORS IN TEL/ABL+ ACUTE LYMPHOBLASTIC LEUKEMIA
- Molecular Cytogenetic Studies of Complex Karyotypes in Myelodysplastic Syndromes (MDS): Conventional Cytogenetics, FISH and Multiplex FISH (mFISH/mBAND)
- MOLECULAR CYTOGENETIC STUDY OF CHILDHOOD T-ALL
- MOLECULAR CYTOGENETIC STUDY OF IMMUNOFLUORESCENTLY LABELED PLASMA CELLS AND PROGNOSTIC SIGNIFICANCE OF CLONAL CHROMOSOMAL ABERRATIONS IN 208 PATIENS WITH MULTIPLE MYELOMA
- Molecular Cytogenetic Study of Immunofluorescently Labeled Plasma Cells and Prognostic Significance of Clonal Chromosomal Aberrations in Multiple Myeloma.
- Molekulárně cytogenetická analýza buněk difúzních gliomů
- Molekulárně cytogenetická analýza buněk mozkových tumorů
- Molekulárně cytogenetická analýza buněk mozkových tumorů
- Neinvazivní diagnostika karcinomu močového měchýře metodou I-FISH
- Periferní T gamma/delta pozitivní hepatosplenický lymfom u pacientky po transplantaci ledviny.
- PROGNOSTIC SIGNIFICANCE OF ADDITIONAL CHROMOSOMAL ABERRATIONS IN CHILDREN WITH ETV6-AML1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
- PROGNOSTIC SIGNIFICANCE OF COMPLEX CHROMOSOMAL REARRANGEMENTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
- PROGNOSTIC SIGNIFICANCE OF TELOMERE LENGTH, MOLECULAR CYTOGENETIC FINDINGS AND IMMUNOPHENOTYPIC FEATURES IN PATIENTS WITH B-CHRONIC LYMPHOCYTIC LEUKEMIA
- Přesmyk z lymfoidní do myeloidní linie během prednisonové předfáze u dětí léčených podle protokolu ALL IC BFM2002
- Putative Monosomy 5 In Myelodysplastic Syndromes (MDS) Is Probably Resulting From Chromothripsis
- SIGNIFICANCE OF ADDITIONAL STRUCTURAL ABERRATIONS IN BONE MARROW CELLS OF 115 CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND HIGH HYPERDIPLOIDY
- Sledování klonálního vývoje u B-CLL metodou I-FISH
- Standard Dose Chemotherapy 3+7 Induces Complete Remission in Patients Over 80 Years Old with Single-Lineage Acute Myeloid Leukemias and Normal Karyotype
- TELOMERE LENGTH EVALUATION IN PATIENTS WITH UNTREATED B-CHRONIC LYMPHOCYTIC LEUKEMIA - CORRELATION WITH OTHER MOLECULAR, CYTOGENETIC AND IMMUNOPHENOTYPIC FEATURES
- THE PREVALENCE OF GATA-2 MUTATION AMONG PEDIATRIC PATIENTS WITH MYELODYSPLASTIC SYNDROME IN CZECH REPUBLIC
- The Prognostic Significance of TP53
- THE ROLE OF TP53 MUTATIONS IN LOW-RISK MDS PATIENTS
- THE UNUSUAL MLL REARRANGEMENT IN ACUTE MYELOID LEUKEMIA
- TRACKING OF THE PRELEUKEMIC PERIOD IN SECONDARY ACUTE LEUKEMIAS REVEALS MULTIPOTENT PROGENITOR AS A TARGET OF MLL REARRANGEMENTS
- TRUE MONOSOMY OF CHROMOSOME 5 IS PRESUMABLY NOT AN ISOLATED CYTOGENETIC ENTITY IN MDS
- Význam metody I-FISH pro neinvazivní diagnostiku karcinomu močového měchýře.
- Význam molekulárně cytogenetické analýzy nádorových buněk pro diagnostiku a léčbu oligodendrogliomů
Články v Klinické onkologii
- Molekulárně cytogenetická analýza chromozomových aberací v buňkách nízkostupňových gliomů a její přínos pro klasifikaci nádoru
- Představení pracoviště URC-CMG. University Research Center – Czech Myeloma Group - krátky popis vzniku a aktivit
- Příklady využití:Výsledky molekulárně cytogenetické analýzy imunofluorescenčně značených plasmatických buněk u pacientů s MM zařazených ve studii CMG 2002
